Information Library
Phase II/III
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Hepatitis B Vaccine-Successful Study Strategy in Asia
November 9, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia. -
Coordinating Safety Across Functions and Phases
November 3, 2009
A customer faced significant challenges with clinical and post-marketing safety. Without previous drug safety experience, they needed an ally who could provide a full range of safety and risk management solutions. -
Enabling Transformation
September 30, 2009
Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company. -
QUINTILES INCREASES CAPACITY TO SUPPORT EUROPEAN CLINICAL TRIALS
September 24, 2009 - Quintiles Transnational Corp. today announced the opening of an expanded regional facility near Edinburgh, Scotland. Located within the Alba Campus, a research and development center near Edinburgh, the 115,000-square-foot building hosts more than 500 employees and has space for Quintiles Clinical Development Services, including Project Management, Regulatory Affairs and Data Management. -
Nasal Influenza Vaccine
September 22, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a nasal influenza vaccine study in Argentina, Brazil and South Africa. -
Changing the Face of Cancer Research
August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, at TMD, a Quintiles Central Laboratory, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. -
DIA Latin America 2009
September 23 - September 25, 2009
6th Annual Latin American Congress of Clinical Research -
Testing Disaster Readiness for Our Customer's Protection
August 10, 2009
Learn how Quintiles' planning protects trial data and provides seamless business continuity for clinical trials. -
Sub-Saharan Africa Phase II/III Fact Sheet
July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond. -
Validated Biomarker Menu
July 14, 2009
A comprehensive menu of validated cell, fluid and tissue based biomarker assays.